Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension: A Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Stanford University
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Participant Survey
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.
Investigators
Paul Wang
Professor of Medicine
Stanford University
Eligibility Criteria
Inclusion Criteria
- •18 years or older with an established diagnosis of essential hypertension
Exclusion Criteria
- •Patients on more than 2 antihypertensives at time of enrollment
- •Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
- •Renal artery stenosis
- •Primary hyperaldosteronism
- •Cushing syndrome
- •Coarctation of the aorta
- •Drug-induced hypertension
- •Pheochromocytoma
- •Obstructive sleep apnea
- •Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
Outcomes
Primary Outcomes
Participant Survey
Time Frame: 12 weeks
A survey regarding usability and feedback about the intervention completed by participants. Questions 1 through 5 were rated on a scale of 1 (strongly disagree) to 7 (strongly agree); question 6 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful).
Physician Survey
Time Frame: 12 weeks
A survey regarding usability and feedback about the intervention completed by physicians. Physicians provided survey responses, but were not enrolled in the study. Questions 1, 2, and 3 were rated on a scale of 1 (strongly agree) to 7 (strongly disagree); question 4 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful); question 5 was rated on a scale of 1 (extremely pleased) to 7 (extremely displeased).
Change in Blood Pressure
Time Frame: Assessed at baseline and week 12
Change in systolic and diastolic blood pressure (SBP and DBP).